At Cape Fear Physical Medicine and Rehab, we are committed to helping individuals improve their health, manage chronic conditions, and achieve sustainable weight loss
In my clinical experience, the pattern is similar for both medications: Weeks 14: Nausea is most common, especially after meals
however, rifampin should be used with caution in pregnant patients
Retatrutide is a newer weight loss medication that targets multiple hormone receptorsGLP-1, GIP, and glucagoncompared to semaglutide, which only targets GLP-1
You want to get pregnant: Semaglutide should not be taken while pregnant or breastfeeding
To maintain that weight loss, continued use of the medication may be necessary, as stopping semaglutide can lead to rebound weight gain